Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The HepConnect initiative aims to expand testing, harm reduction and health care infrastructure.
“This is a step in the right direction, but more work needs to be done.”
But the health secretary does not support safe injection sites.
A new meta-analysis finds this population has a high success rate on hepatitis C therapy.
Matt Heskett discusses his journey with hepatitis C for the first time with the press.
Indianapolis native Matt Heskett beat both opioid addiction and hep C. Now he’s paying his good fortune forward with activism and education.
Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.
After a reformulated version of the opioid painkiller hit the market in 2010, some with opioid use disorder migrated from pills to heroin.
The opioid epidemic is likely fueling increased rates of deceased organ donors categorized as posing a high risk of passing on such viruses.
Researchers say given the many associated downsides and risks, opioids should not be a first choice for chronic noncancer pain.
A recent survey of such sites found high rates of hepatitis C among patrons, but treatment for the virus was rarely offered on-site.
He said it would enable drug use, but Jeff Sessions also influenced the veto.
Inhabitants are facing mounting hepatitis A, addiction and overdose risks.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
If pain drives you to sharing needles and drug-related equipment, be aware of the risks such as hepatitis B, C, and HIV transmission.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.